2800 Federal Register / Vol. 87, No. 12 / Wednesday, January 19, 2022 / Notices 

Based on a review of the information 

collection since our last request for 

OMB approval, we have made no 

adjustments to our burden estimate. Our 

estimates for the recordkeeping burden 

and the reporting burden are based on 

our experience with similar 

recordkeeping activities and the number 

of registrations and cancellations 

received in the past 3 years. 

Dated: January 11, 2022. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2022–00863 Filed 1–18–22; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Meeting of the Advisory Committee on 

Heritable Disorders in Newborns and 

Children 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Notice. 

SUMMARY: In accordance with the Public 

Health Service Act and the Federal 

Advisory Committee Act, this notice 

announces that the Advisory Committee 

on Heritable Disorders in Newborns and 

Children (ACHDNC or Committee) has 

scheduled a public meeting to be held 

on Thursday, February 10, 2022, and 

Friday, February 11, 2022. Information 

about the ACHDNC and the agenda for 

this meeting can be found on the 

ACHDNC website at https://

www.hrsa.gov/advisory-committees/ 

heritable-disorders/index.html. 

DATES: Thursday, February 10, 2022, 

from 10:00 a.m.–3:00 p.m. Eastern Time 

(ET) and Friday, February 11, 2022, 

from 10 a.m.–2:30 p.m. ET. 

ADDRESSES: This meeting will be held 

via webinar. While this meeting is open 

to the public, advance registration is 

required. 

Please visit the ACHDNC website for 

information on registration: https://

www.hrsa.gov/advisory-committees/ 

heritable-disorders/index.html. The 

deadline for registration is 12:00 p.m. 

ET on February 9, 2022. Instructions on 

how to access the meeting via webcast 

will be provided upon registration. 

FOR FURTHER INFORMATION CONTACT: 

Alaina Harris, Maternal and Child 

Health Bureau, HRSA, 5600 Fishers 

Lane, Room 18W66, Rockville, 

Maryland 20857; 301–443–0721; or 

ACHDNC@hrsa.gov. 

SUPPLEMENTARY INFORMATION: ACHDNC 

provides advice and recommendations 

to the Secretary of Health and Human 

Services (Secretary) on the development 

of newborn screening activities, 

technologies, policies, guidelines, and 

programs for effectively reducing 

morbidity and mortality in newborns 

and children having, or at risk for, 

heritable disorders. The ACHDNC 

reviews and reports regularly on 

newborn and childhood screening 

practices, recommends improvements in 

the national newborn and childhood 

screening programs, and fulfills 

requirements stated in the authorizing 

legislation. In addition, ACHDNC’s 

recommendations regarding inclusion of 

additional conditions for screening on 

the Recommended Uniform Screening 

Panel (RUSP), following adoption by the 

Secretary, are evidence-informed 

preventive health services provided for 

in the comprehensive guidelines 

supported by HRSA pursuant to section 

2713 of the Public Health Service Act 

(42 U.S.C. 300gg–13). Under this 

provision, non-grandfathered group 

health plans and health insurance 

issuers offering non-grandfathered 

group or individual health insurance are 

required to provide insurance coverage 

without cost-sharing (a co-payment, coinsurance, or deductible) for preventive 

services for plan years (i.e., policy years) 

beginning on or after the date that is one 

year from the Secretary’s adoption of the 

condition for screening. 

During the February 10–11, 2022 

meeting, ACHDNC will hear from 

experts in the fields of public health, 

medicine, heritable disorders, rare 

disorders, and newborn screening. 

Agenda items include the following: 

(1) Final evidence-based review report 

on the Mucopolysaccharidosis type II 

(MPS II) condition nomination for 

possible inclusion on the RUSP. 

Following this report, the ACHDNC 

expects to vote on whether to 

recommend to the Secretary adding 

MPS II to the RUSP. 

(2) A presentation on phase two of the 

evidence-based review for 

Guanidinoacetate methyltransferase 

(GAMT) deficiency. 

(3) An update on the Krabbe disease 

condition nomination. 

(4) A possible vote on whether to 

move Krabbe disease forward to full 

evidence-based review. 

(5) Overview of ACHDNC consumerfriendly resources. 

(6) A presentation on healthy equity 

in newborn screening. 

The agenda for this meeting includes 

a potential vote which may lead to a 

decision to recommend a nominated 

condition (MPS II) to the RUSP. As 

noted in the agenda items, the 

Committee may hold a vote on whether 

or not to recommend a nominated 

condition (Krabbe disease) to full 

evidence-based review, and will hear 

presentations on the evidence-based 

review for Guanidinoacetate 

methyltransferase deficiency, any of 

which may lead to a recommendation to 

add or not add a condition/conditions to 

the RUSP at a future time. 

Agenda items are subject to change as 

priorities dictate. Information about the 

ACHDNC, including a roster of members 

and past meeting summaries, is also 

available on the ACHDNC website listed 

above. 

Members of the public also will have 

the opportunity to provide comments. 

Public participants providing oral 

comments may submit written 

statements in advance of the scheduled 

meeting. Oral comments will be 

honored in the order they are requested 

and may be limited as time allows. 

Subject to change: Members of the 

public registered to submit oral public 

comments on MPS II are tentatively 

scheduled to provide their statements 

on Thursday, February 10, 2022. 

Members of the public registered to 

provide statements on all other newborn 

screening related topics are tentatively 

scheduled for Friday, February 11, 2022. 

Requests to provide a written statement 

or make oral comments to the ACHDNC 

must be submitted via the registration 

website by 12:00 p.m. ET on Friday, 

February 4, 2022. 

Individuals who need special 

assistance or another reasonable 

accommodation should notify Alaina 

Harris at the address and phone number 

listed above at least 10 business days 

prior to the meeting. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2022–00896 Filed 1–18–22; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Notice of Publication of the Trusted 

Exchange Framework and Common 

Agreement 

AGENCY: Office of the National 

Coordinator for Health Information 

Technology, Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: This notice fulfills an 

obligation under the Public Health 

Service Act (PHSA), which requires the 


jspears on DSK121TN23PROD with NOTICES1